Overview of the Management of Chronic Non-Cancer Pain in Patients with Spinal Disease
10.4184/jkss.2018.25.3.91
- Author:
Hun Kyu SHIN
1
;
Woo Dong NAM
;
Dong Soo KIM
;
Jin Hwan KIM
;
Sung Kyu KIM
;
Tae Keun AHN
;
Sung Soo KIM
Author Information
1. Department of Orthopedic Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Publication Type:Multicenter Study
- Keywords:
Chronic non-cancer pain;
Analgesic;
End of dose failure (EDF);
Breakthrough pain
- MeSH:
Analgesics;
Breakthrough Pain;
Chronic Pain;
Humans;
Korea;
Pain Management;
Spinal Diseases;
Spine
- From:Journal of Korean Society of Spine Surgery
2018;25(3):91-98
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
STUDY DESIGN: Cross-sectional, multi-center survey study. OBJECTIVES: The objective of this study was to investigate the pain status, pain management methods, and pain experience after treatment among patients suffering from chronic non-cancer pain due to spinal disease. SUMMARY OF LITERATURE REVIEW: No thorough investigation of the current status of chronic non-cancer pain management in patients with spinal disease has recently been reported. MATERIALS AND METHODS: We surveyed 330 patients with chronic non-cancer pain who visited spine clinics in Korea. RESULTS: Prior to treatment, 86.7% of the patients had severe pain and 99.4% of the patients had taken oral analgesics for pain control. After treatment, the percent of patients with severe pain was reduced to 42.1%, and 52.4% of patients responded that they experienced intermittent pain. End of dose failure was experienced by 29.1% of patients, and 41.7% of patients experienced pain again 3–6 hours after taking analgesics. Furthermore, 8.2% of patients experienced breakthrough pain, and 29.1% of patients experienced pain that interfered with sleeping. CONCLUSIONS: Many patients with chronic pain reported experiencing pain due to end of dose failure after medication. As the causes of chronic pain are complex, appropriate analgesics should be considered and selected for effective pain management.
